Posted on 03/15/2020 9:49:45 AM PDT by BenLurkin
Earlier, the Welt am Sonntag German newspaper reported that U.S. President Donald Trump had offered funds to lure CureVac to the United States, and the German government was making counter-offers to tempt it to stay.
There was no comment immediately available from the U.S. embassy in Berlin when contacted by Reuters over the report.
“The German government is very interested in ensuring that vaccines and active substances against the new coronavirus are also developed in Germany and Europe,” a Health Ministry spokeswoman said, confirming a quote in the newspaper.
(Excerpt) Read more at reuters.com ...
Location of production seems to be of strategic importance. I’m not sure I care very much where it is developed.
If they make an effective vaccine, why couldn’t they have production facilities in several continents, ramp up production and the vaccine is available more or less locally.
They found a way to kill Coronavirus; they told Hiliary it was going to testify against her.
Exactly. I don’t see why relocating from Germany is important. Global production seems like a sensible business goal no matter where HQ is.
bttt!
Wow,great,let’s fight over a potential vaccines production location.
There’s probably some sort of weird EU laws that govern it if it’s within EU territory. Bureaucracy wins again!
...”However, one US official described the report as “completely over the top”. The U.S. government has spoken to more than 25 companies that could potentially help develop a vaccine. “We will continue to speak to any company that may be able to help. And any solution would be shared with the world.”...
This is an extract from the translated German newspaper reporting that Trump tried to buy exclusive rights to the vaccine (which doesn’t exist).
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.